2006 Annual Meeting | Contemporary Clinical Issues Plenary
| 09:00 AM - 11:00 AM |
Refreshments
|
|
| 09:00 AM - 11:00 AM |
Abstract Presenter: Orchiectomy for Suspected Microscopic Tumor in Patients with Paraneoplastic Anti-Ma2 Encephalitis
Rose M. Mathew, DO |
|
| 09:00 AM - 11:00 AM |
Discussant: Orchiectomy for Suspected Microscopic Tumor in Patients with Paraneoplastic Anti-Ma2 Encephalitis
Kurt A. Jaeckle, MD, FAAN |
|
| 09:00 AM - 11:00 AM |
Abstract Presenter: Migraine with Aura is Associated with Increased Risk of Coronary Heart Disease in Apparently Healthy Women
Tobias Kurth, MD, ScD, FAAN |
|
| 09:00 AM - 11:00 AM |
Discussant: Migraine with Aura is Associated with Increased Risk of Coronary Heart Disease in Apparently Healthy Women
Richard B. Lipton, MD, FAAN |
|
| 09:00 AM - 11:00 AM |
Abstract Presenter: The Prevalence of Pathological Gambling, Hypersexuality, and Compulsive Shopping in Parkinson's Disease: A Prospective Study
Valerie Voon, MD FRCPC |
|
| 09:00 AM - 11:00 AM |
Discussant: The Prevalence of Pathological Gambling, Hypersexuality, and Compulsive Shopping in Parkinson's Disease: A Prospective Study
Oksana Suchowersky, MD, FAAN |
|
| 09:00 AM - 11:00 AM |
Lafora Disease and How an Ancient Prokaryotic Sequence Protects Us Again Starch on the Brain
Berge A. Minassian, MD |
|
| 09:00 AM - 11:00 AM |
From Neurodevelopment to Neurodegeneration: An Older Face of the Fragile X Gene
Paul J. Hagerman, MD, PhD |
|
| 09:00 AM - 11:00 AM |
Can this Brain be Saved? Otpimizing Acute Stroke Management with Penumbra and Vessel Imaging
Jeffrey L. Saver, MD, FAAN |
| Kurt A. Jaeckle, MD, FAAN | Dr. Jaeckle has stock in Entegrion, Inc. |
| Richard B. Lipton, MD, FAAN | Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care. |
| Oksana Suchowersky, MD, FAAN | Dr. Suchowersky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos/Alexion. The institution of Dr. Suchowersky has received research support from Roche. The institution of Dr. Suchowersky has received research support from Wave LifeSciences. The institution of Dr. Suchowersky has received research support from CHDI. Dr. Suchowersky has received publishing royalties from a publication relating to health care. Dr. Suchowersky has received publishing royalties from a publication relating to health care. |
| Jeffrey L. Saver, MD, FAAN | Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical. |
| Berge A. Minassian, MD | No disclosure on file |
| Tobias Kurth, MD, ScD, FAAN | Dr. Kurth has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TotalEnergies. Dr. Kurth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly & Company. Dr. Kurth has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ. Dr. Kurth has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. The institution of Dr. Kurth has received research support from German Joint Committee. The institution of Dr. Kurth has received research support from Ministry of Health. |
| Rose M. Mathew, DO | No disclosure on file |
| Paul J. Hagerman, MD, PhD | No disclosure on file |
| Valerie Voon, MD FRCPC | No disclosure on file |